Literature DB >> 3596338

Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

M Deakin, H P Glenny, J K Ramage, J G Mills, W L Burland, J G Williams.   

Abstract

The effects of single doses of cimetidine 800, 1200, and 1600 mg, given at 2300 h or 800, and 1600 mg at 1800 h, have been studied in patients with duodenal ulcer disease in symptomatic remission, and compared with cimetidine 400 mg bd (0800 h and 2300 h) and ranitidine 300 mg (given at 1800 h) respectively. A dose related reduction in intragastric acidity was seen. All single nocturnal (2300 h) doses of cimetidine produced anacidity overnight. This was not achieved with dosing at 1800 h although the duration of inhibition of gastric acidity was longer. Inhibition of overnight acid and pepsin outputs were similarly dose and timing related, but inhibition of peptic activity was much less after dosing at 1800 h. Cimetidine 1600 mg and ranitidine 300 mg were similar in their effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596338      PMCID: PMC1432890          DOI: 10.1136/gut.28.5.566

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Vagotomy for Gastroduodenal Ulcer.

Authors:  L R Dragstedt
Journal:  Ann Surg       Date:  1945-12       Impact factor: 12.969

2.  On central tendency and the meaning of mean for pH values.

Authors:  A R Feinstein
Journal:  Anesth Analg       Date:  1979 Jan-Feb       Impact factor: 5.108

3.  Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

4.  Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration.

Authors:  J P Pearson; R Ward; A Allen; N B Roberts; W H Taylor
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

5.  Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders.

Authors:  T Gledhill; M Buck; R H Hunt
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

6.  Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.

Authors:  T Gledhill; O M Howard; M Buck; A Paul; R H Hunt
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

7.  pH or hydrogen-ion concentration in statistics?

Authors:  M Lucas
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

8.  Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers.

Authors:  A Ireland; D G Colin-Jones; P Gear; P L Golding; J K Ramage; J G Williams; R J Leicester; C L Smith; G Ross; J Bamforth
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

9.  Factors influencing healing of duodenal ulcer. Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal.

Authors:  S K Lam; C L Lai; L N Lee; K H Fok; M M Ng; K F Siu
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

10.  Cobalamin-specific R binder in pernicious anemia gastric juice: production by digestive enzyme action on saliva R binder.

Authors:  B C Herzlich; V Herbert
Journal:  Am J Gastroenterol       Date:  1985-11       Impact factor: 10.864

View more
  7 in total

1.  A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating duodenal ulcers.

Authors:  M Okada; M Arita; M Iida; T Yao; T Sakurai; K Hoshiko; K Maeda; Y Okada; K Sakamoto
Journal:  Gastroenterol Jpn       Date:  1992-04

2.  Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.

Authors:  S G Chiverton; D W Burget; R H Hunt
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 3.  Gastroenterology in the armed forces.

Authors:  G Milton-Thompson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

4.  Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.

Authors:  G Bianchi Porro; F Parente; O Sangaletti
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

6.  Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.

Authors:  Atsushi Takeda; Takayuki Toda; Takuma Fujii; Noriaki Matsui
Journal:  Clin Exp Nephrol       Date:  2009-05-16       Impact factor: 2.801

7.  Early evening dosing of ranitidine. Comparison with nighttime dosing of ranitidine or cimetidine in duodenal ulceration.

Authors:  J S Dixon; R S Ehsanullah; J G Mills; J R Wood
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.